University of Insubria   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Como Italy (1998)

Organization Overview

First Clinical Trial
2002
NCT00732927
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Università degli Studi dell'Insubria | University of Insubria, Varese, Italy | University of Insubria, Varese, ITALY

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Remodeling (Phase 4)

Heart Diseases (Phase 4)

HIV Infections (Phase 4)

Hypercholesterolemia (Phase 2)

Hypertension (Phase 4)

Renal Insufficiency (Phase 4)

Retinal Vein Occlusion (Phase 3)

Thromboembolism (Phase 4)

Thrombosis (Phase 3)

Urinary Bladder, Overactive (Phase 3)

Vaginitis (Phase 3)

Venous Thromboembolism (Phase 4)

Venous Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 19
  • # of Trial APIs: 23